Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MGAT4B - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
HLA-B - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
HLA-G - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
APLP2 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
DDOST - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
CYB5R3 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
GEO DataSets Gene Profile neighbors Chromosome neighbors
CLPTM1 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
ABHD12 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
PPP2R1A - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
NELFCD - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
TBC1D9B - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
SLC25A39 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
MPV17 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
FLII - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
HADHA - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on